Why We Do Not Recommend That Women With Breast Cancer Receive Adjuvant Treatment With a CDK4/6 Inhibitor

Tannock, I. F., Khan, Q. J., & Fojo, T. (2025). Why We Do Not Recommend That Women With Breast Cancer Receive Adjuvant Treatment With a CDK4/6 Inhibitor. Journal of Clinical Oncology. https://doi.org/10.1200/jco-24-02683
Authors:
Ian F Tannock
Qamar J Khan
Tito Fojo
Affiliated Authors:
Tito Fojo
Columbia Affiliation:
elink
Publication Type:
Article
Unique ID:
10.1200/jco-24-02683
PMID:
40228181
DOI:
10.1200/jco-24-02683
Journal:
Journal of Clinical Oncology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: